Epstein Secrets

ntity Value Adjusted Tax Cost Original Cost Unrealized Gain/Loss EFTA01540371 Est. Annual Inc. Accrued Div. Yield US Small/Mid Cap Equity DEUTSCHE BK AG LDN BRH 11.79 DBL LONG ETN38 25154H-55-8 DAG 50,000.000 589,500.00 352,529.00 236,971.00 Account W23560001 Page 5 of 32 Consolidated Stateme

-26 CL B1 5.33684% 08/25/2033 DTD 06/01/2003 12669E-RR-9 IMPAC CMB TRUST SER 2005-2 CL 1M1 VAR RT 04/25/2035 DTD 03/03/2005 45254N-NB-9 CCC /B2 MORTGAGEIT TRUST 2005-2 CL 1M1 VAR RT 05/25/2035 DTD 04/27/2005 61915R-AD-8 BBB /NR P CHASE MORTGAGE FINANCE CORPORATION REMIC 2007-A1 CL 2A4 2.99199% 02/25/2037 DTD 02/01/200

ntity Value Adjusted Tax Cost Original Cost Unrealized Gain/Loss EFTA01540260 Est. Annual Inc. Accrued Div. Yield US Small/Mid Cap Equity DEUTSCHE BK AG LDN BRH 12.48 DBL LONG ETN38 25154H-55-8 DAG 50,000.000 624,000.00 352,529.00 271,471.00 Account W23560001 Page 5 of 43 Consolidated Stateme

For the Period 11/1/12 to 11/30/12 Price US Fixed Income IMPAC CMB TRUST SER 2005-2 CL 1M1 VAR RT 04/25/2035 DTD 03/03/2005 45254N-NB-9 CCC /B2 MORTGAGEIT TRUST 2005-2 CL 1M1 VAR RT 05/25/2035 DTD 04/27/2005 61915R-AD-8 BBB /NR PRUDENTIAL FINANCIAL INC VAR RT 06/15/2043 DTD 11/19/2012 744320-AM-4 BBB /BAA SOUTHERN CA

dated Statement Page 8 EFTA01540460 FINANCIAL TRUST COMPANY INC ACCT. W23560001 For the Period 1/1/13 to 1/31/13 Price US Small/Mid Cap Equity DEUTSCHE BK AG LDN BRH DBL LONG ETN38 25154H-55-8 DAG P KERYX BIOPHARMACEUTICALS INC Total US Small/Mid Cap Equity 492515-10-1 KERX $583,400.00 $352,529.00

For the Period 1/1/13 to 1/31/13 Price US Fixed Income IMPAC CMB TRUST SER 2005-2 CL 1M1 VAR RT 04/25/2035 DTD 03/03/2005 45254N-NB-9 CCC /CAA MORTGAGEIT TRUST 2005-2 CL 1M1 VAR RT 05/25/2035 DTD 04/27/2005 61915R-AD-8 BBB /NR CHASE MORTGAGE FINANCE CORPORATION REMIC 2007-A1 CL 2A4 2.99199% 02/25/2037 DTD 02/01/2007